Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald H Mahoney

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Cancer Genetics and Cytogenetics|June 9, 2007
Prognostic significance of cytogenetically detected chromosome 21 anomalies in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group studyLinda D Cooley, Saleen Chenevert, Jonathan J Shuster, et al.
Magnetic Resonance Imaging|January 12, 2010
Assessment of cardiac iron by MRI susceptometry and R2* in patients with thalassemiaZhiyue J Wang, Roland Fischer, Zili Chu, et al.
Neuro-Oncology|October 21, 2003
Phase 2 study of idarubicin in pediatric brain tumors: Pediatric Oncology Group study POG 9237ZoAnn E Dreyer, Richard P Kadota, Clinton F Stewart, et al.
American Journal of Hematology|May 31, 2020
Novel dose escalation to predict treatment with hydroxyurea (NDEPTH): A randomized controlled trial of a dose-prediction equation to determine maximum tolerated dose of hydroxyurea in pediatric sickle cell diseaseAlex George, Bogdan Dinu, Norma Estrada, et al.
Blood|December 15, 2005
Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpuraCarolyn M Bennett, Zora R Rogers, Daniel D Kinnamon, et al.
Pediatric Blood & Cancer|October 22, 2008
One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximabBrigitta U Mueller, Carolyn M Bennett, Henry A Feldman, et al.
The Journal of Clinical Investigation|October 4, 2017
Mutations in signal recognition particle SRP54 cause syndromic neutropenia with Shwachman-Diamond-like featuresRaphael Carapito, Martina Konantz, Catherine Paillard, et al.
Nature Genetics|October 13, 2015
The genomic landscape of juvenile myelomonocytic leukemiaElliot Stieglitz, Amaro N Taylor-Weiner, Tiffany Y Chang, et al.
Nature Genetics|December 30, 2015
Corrigendum: The genomic landscape of juvenile myelomonocytic leukemiaElliot Stieglitz, Amaro N Taylor-Weiner, Tiffany Y Chang, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Cancer Genetics and Cytogenetics|June 9, 2007
Prognostic significance of cytogenetically detected chromosome 21 anomalies in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group studyLinda D Cooley, Saleen Chenevert, Jonathan J Shuster, et al.
Magnetic Resonance Imaging|January 12, 2010
Assessment of cardiac iron by MRI susceptometry and R2* in patients with thalassemiaZhiyue J Wang, Roland Fischer, Zili Chu, et al.
Neuro-Oncology|October 21, 2003
Phase 2 study of idarubicin in pediatric brain tumors: Pediatric Oncology Group study POG 9237ZoAnn E Dreyer, Richard P Kadota, Clinton F Stewart, et al.
American Journal of Hematology|May 31, 2020
Novel dose escalation to predict treatment with hydroxyurea (NDEPTH): A randomized controlled trial of a dose-prediction equation to determine maximum tolerated dose of hydroxyurea in pediatric sickle cell diseaseAlex George, Bogdan Dinu, Norma Estrada, et al.
Blood|December 15, 2005
Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpuraCarolyn M Bennett, Zora R Rogers, Daniel D Kinnamon, et al.
Pediatric Blood & Cancer|October 22, 2008
One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximabBrigitta U Mueller, Carolyn M Bennett, Henry A Feldman, et al.
The Journal of Clinical Investigation|October 4, 2017
Mutations in signal recognition particle SRP54 cause syndromic neutropenia with Shwachman-Diamond-like featuresRaphael Carapito, Martina Konantz, Catherine Paillard, et al.
Nature Genetics|October 13, 2015
The genomic landscape of juvenile myelomonocytic leukemiaElliot Stieglitz, Amaro N Taylor-Weiner, Tiffany Y Chang, et al.
Nature Genetics|December 30, 2015
Corrigendum: The genomic landscape of juvenile myelomonocytic leukemiaElliot Stieglitz, Amaro N Taylor-Weiner, Tiffany Y Chang, et al.
Pageof 4